1. Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper 
Dimitrios Farmakis, Julian Alvarez, Tuvia Ben Gal, Dulce Brito, Francesco Fedele, Candida Fonseca, Anthony C. Gordon, Israel Gotsman, Elena Grossini, Fabio Guarracino, Veli-Pekka Harjola, Yaron Hellman, Leo Heunks, Visnja Ivancan, Apostolos Karavidas, Matti Kivikko, Vladimir Lomivorotov, Dan Longrois, Josep Masip, Marco Metra, Andrea Morelli, Maria Nikolaou, Zoltán Papp, Alexander Parkhomenko, Gerhard Poelzl, Piero Pollesello, Hanne Berg Ravn, Steffen Rex, Hynek Riha, Sven-Erik Ricksten, Robert H.G. Schwinger, Bojan Vrtovec, M. Birhan Yilmaz, Marzenna Zielinska, John Parissis 
International Journal of Cardiology 
Volume 222, Pages (November 2016)
DOI: /j.ijcard
Copyright © 2016 The Authors Terms and Conditions

2. Fig. 1
Levosimendan's main mechanisms of action (modified from Papp Z et al. Int J Cardiol 2012;159:82-7).
International Journal of Cardiology  , DOI: ( /j.ijcard )
Copyright © 2016 The Authors Terms and Conditions

3. Fig. 2
Clinical scenarios in the context of acutely decompensated heart failure, in which levosimendan may play a beneficial role.
International Journal of Cardiology  , DOI: ( /j.ijcard )
Copyright © 2016 The Authors Terms and Conditions

4. Fig. 3
Summary of the favorable effects of levosimendan beyond inotropy, the heart and acute heart failure.
International Journal of Cardiology  , DOI: ( /j.ijcard )
Copyright © 2016 The Authors Terms and Conditions